<DOC>
	<DOCNO>NCT00693576</DOCNO>
	<brief_summary>Patients panel reactive antibody many difficulty find crossmatch-negative kidney transplantation risk post transplantation rejection transplant patient . We evaluate effect simvastatin PRA post transplant outcome sensitize patient . We also perform descriptive study .</brief_summary>
	<brief_title>The Effect Simvastatin Desensitization Panel-Positive Kidney Transplant Candidates</brief_title>
	<detailed_description>The presence panel reactive antibody ( PRAs ) sera renal transplant candidate associate hyperacute delayed humoral immune response graft transplantation . In addition , sensitize patient wait long time find cross-match negative kidney renal transplantation . As result , modality use desensitization include plasmapheresis intravenous immunoglobulin ( IVIG ) combination immunosuppressive drug . However , recently , use statin simvastatin , pravastatin etc . propose safer effective desensitization .</detailed_description>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1. patient ESRD hemodialysis peritoneal dialysis 2 . On wait list renal transplant 3 . PRA 25 % 1 . Pregnant woman 2 . Patients need ongoing blood product 3 . Patients take therapy decrease PRA 4 . Patients list multiorgan transplant kidney 5 . Patients liver failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>renal transplant</keyword>
	<keyword>panel reactive antibody</keyword>
	<keyword>sensitization</keyword>
	<keyword>simvastatin</keyword>
	<keyword>immunological</keyword>
</DOC>